Business Wire

BACARDI-LIMITED

30.3.2021 13:02:15 CEST | Business Wire | Press release

Share
BOMBAY SAPPHIRE® ON A MISSION TO BE THE WORLD’S MOST SUSTAINABLE GIN

After decades spent carefully building sustainable partnerships with farmers and suppliers, BOMBAY SAPPHIRE, the iconic premium gin from family-owned Bacardi Limited, is proud to announce that all 10 of its botanical ingredients are on track to be certified sustainable in 2021. With the suppliers of eight already certified according to the For Life standard, the goal is for the remaining two producers – for grains of paradise from Ghana and liquorice from China – to be certified in the months which follow the lifting of travel restrictions.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20210330005556/en/

This news is a major step towards Bacardi, the largest privately-held spirits company in the world, achieving its 2025 goal of sourcing 100% of its key ingredients from sustainably certified suppliers.

The 10 botanicals, which include juniper from Tuscany, coriander from Morocco, lemon peel from Spain and cubeb berries from Java, are hand selected by BOMBAY SAPPHIRE Master of Botanicals Ivano Tonutti to create the gin’s fresh, bright taste.

Only the finest quality botanicals are selected by Ivano and his work does not end there. The For Life certification awarded by Ecocert S.A., the world’s leading specialist in the certification of sustainable practices, recognizes the commitment of Ivano and Bacardi to only work with suppliers who act responsibly and ensure a sustainable future for farmers, their communities and the environment.

BOMBAY SAPPHIRE has pioneered sustainability in the spirits industry. The brand has long invested in new innovations offering creative solutions to complex challenges. When the BOMBAY SAPPHIRE distillery opened in Laverstoke, England, in 2014 it set a new standard for sustainability by showcasing many such innovations – the distillery’s design was rated ‘outstanding’ by BREEAM , the most recognized environmental assessment for buildings.

“We take a 360-degree approach to sustainability,” says Ivano Tonutti. ”It’s our responsibility to care as much about the farmers and their communities as we do the botanicals they grow and harvest for BOMBAY SAPPHIRE. By looking after their well-being and investing in sustainable farming practices, we are helping to protect the environment and their livelihoods for generations to come.”

An example of this in practice is the village in Ghana where, over a number of years, Bacardi has worked with AIESEC, a local non-governmental organization, to help the community establish itself as an independent farming cooperative – from installing a water pump, which now supplies the village with fresh water, to recruiting an agronomist for expert advice and guidance. This year, the village will harvest its first crop of grains of paradise for BOMBAY SAPPHIRE.

For Life certification gives consumers peace of mind that ingredients are coming from organizations committed to continuous improvement,” says Ecocert CEO Philippe Thomazo. “For Life means that suppliers growing and harvesting the certified botanicals for BOMBAY SAPPHIRE are acting responsibly in every respect.”

Natasha Curtin, VP BOMBAY SAPPHIRE, says: “I am incredibly proud of this latest achievement by Ivano and his team but as an industry, we must all invest in a more sustainable future. Ivano has spent more than 20 years building close relationships with our farmers and suppliers around the world. With his experience and expertise, we have created a blueprint for the sustainable sourcing of botanicals, which we hope will inspire others to do the same.”

Bacardi worked closely with its suppliers to help them achieve For Life certification. To be certified, suppliers must commit to continuous improvement in the following areas:

- the well-being of the people involved in the harvesting and supply of the botanicals;
- the reduction of their environmental impact;
- their responsible purchasing practices;
- and sustainable development at a local level and key stages in the supply chain.

Find out more about the sustainability commitments of Bacardi and its vision to become the most environmentally responsible global spirits company at https://www.bacardilimited.com/corporate-responsibility/environment/ .

Always drink responsibly.

About BOMBAY SAPPHIRE gin
BOMBAY SAPPHIRE, the world's number one premium gin, is created with a unique combination of 10 botanical ingredients sourced from around the globe. In the historic still houses of the BOMBAY SAPPHIRE distillery in Hampshire, England, spirit vapour passes through perforated copper baskets filled by hand with the 10 botanicals. Through this signature distillation process, called vapour infusion , BOMBAY SAPPHIRE perfectly captures the natural, aromatic flavors of each botanical which results in the gin's fresh, bright taste. Awarded a double gold medal in the 2017 San Francisco World Spirits Competition, BOMBAY SAPPHIRE is consistently recognized for crafting the finest quality gin. For more information, please explore www.bombaysapphire.com .

BOMBAY SAPPHIRE is part of the portfolio of Bacardi Limited, with global headquarters in Hamilton, Bermuda. Bacardi Limited refers to the Bacardi group of companies, including Bacardi International Limited.

About Bacardi Limited
Bacardi Limited, the largest privately held spirits company in the world, produces and markets internationally recognized spirits and wines. The Bacardi Limited brand portfolio comprises more than 200 brands and labels, including BACARDÍ® rum, GREY GOOSE® vodka, PATRÓN® tequila, DEWAR’S® Blended Scotch whisky, BOMBAY SAPPHIRE® gin, MARTINI® vermouth and sparkling wines, CAZADORES® 100% blue agave tequila, and other leading and emerging brands including WILLIAM LAWSON’S® Scotch whisky, ST-GERMAIN® elderflower liqueur, and ERISTOFF® vodka. Founded nearly 160 years ago in Santiago de Cuba, family-owned Bacardi Limited currently employs more than 7,000, operates production facilities in 11 countries, and sells its brands in more than 170 countries. Bacardi Limited refers to the Bacardi group of companies, including Bacardi International Limited. Visit www.bacardilimited.com or follow us on Twitter , LinkedIn or Instagram .

About Ecocert Group
With over 30 years of commitment to sustainability and to the development of organic farming worldwide, Ecocert provides stakeholders with support in understanding, implementing and promoting sustainable practices through training, consulting and independent certification services. Ecocert only offers a range of selected, recognized, and demanding standards with high environmental and societal criteria. For organizations willing to go further in the transition, Ecocert also develops innovative programs with higher requirements (Fair For Life, For Life, En Cuisine, etc.). Today the group is also a world leading company in the certification of organic agriculture and cosmetic, present in more than 130 countries through an international network of 31 subsidiaries with over 1,700 collaborators. To find out more on how Ecocert acts for a sustainable world, please visit: www.ecocert.com or follow Ecocert on LinkedIn or Facebook .

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Biocytogen Grants Taisho Pharmaceutical a License to its RenNano® Fully Human Heavy Chain-Only Antibody Discovery Platform30.3.2026 13:00:00 CEST | Press release

Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (Biocytogen, SSE: 688796; HKEX: 02315), a global biotechnology company that drives the research and development of novel antibody-based drugs with innovative technologies, today announced that it has entered into a platform license agreement with Taisho Pharmaceutical Co., Ltd. (“Taisho”), granting Taisho the right to access and use Biocytogen’s proprietary RenNano® fully human heavy chain-only antibody (HCAbs) discovery platform for its internal research and development programs. Under the terms of the agreement, Taisho will leverage RenNano® mice to enable the generation and screening of fully human HCAbs in vivo and to support downstream research associated with antibody discovery. Financial terms of the agreement have not been disclosed. “We are very pleased to enter into this collaboration with Taisho,” said Dr. Yuelei Shen, President and CEO of Biocytogen. “RenNano® is a robust and powerful fully human VHH discovery platform that pro

Meiji Seika Pharma Invests in Centivax to Develop Next Generation Universal Vaccine Platform30.3.2026 13:00:00 CEST | Press release

Meiji Seika Pharma Co., Ltd. (Head Office: Chuo-ku, Tokyo, President and Representative Director: Toshiaki Nagasato) today announced a strategic investment in Centivax, Inc. (Head Office: South San Francisco, CA, USA), a biotechnology company developing next-generation vaccines and therapies for universal protection against highly diverse targets. Centivax’s lead program includes a universal seasonal influenza vaccine (Centi-Flu 01) currently in a Phase 1 clinical study. Unlike conventional seasonal flu vaccines, which must be manufactured annually based on recommended candidate vaccine viruses, Centivax’s platform focuses both antibody and cellular immune responses on conserved regions of the influenza virus that cannot mutate and are shared across strains and distant subtypes. This approach aims to generate broad, consistent, and durable immunity against both seasonal and pandemic influenza. Meiji’s strategic investment aims to accelerate the advancement of Centi-Flu 01 and further a

Samsung Biologics Strike: Labor Union Warns of CDMO Supply Chain Risks Following Overwhelming Vote30.3.2026 11:52:00 CEST | Press release

Union members overwhelmingly approve strike action with 95.52% voting in favor on a 95.38% turnout, clearing the final legal hurdle after mediation ceased.Union emphasizes this is a fight against structural corporate governance issues, citing unresolved allegations concerning unfair labor practices and ESG compliance risks.Management adhered to a group-level wage guideline rather than bargaining on the basis of Samsung Biologics' own performance, exposing a lack of independent bargaining authority. The Samsung Biologics Labor Union (President: Jaesung Park), representing approximately 75% of the company's total employees, announced today that its members have overwhelmingly voted in favor of a strike, with 95.52% voting in favor on a 95.38% turnout during a voting period from March 24 to March 29. Following the Incheon Regional Labor Relations Commission's decision to cease mediation, the union has now secured the legal mandate to strike. The union stressed that this strike is not mere

The Premier Jumping League (PJL) Launches with a Record-Breaking $300 Million Guaranteed Prize Pot, Defining a New Era for Showjumping30.3.2026 11:00:00 CEST | Press release

The PJL empowers riders to compete as full-time professional athletes while working towards a sustainable economic model for the sport. Backed by McCourt Global and shaped by a leadership team with decades of experience in equestrian competition, sport, and entertainment, the PJL sets a new, sustainable, and globally relevant standard for elite jumping. Sixteen teams will compete across fourteen iconic international venues throughout Europe, North America, and the Middle East when the inaugural season opens in March 2027. The Premier Jumping League (PJL) launches with a record-breaking $300 million guaranteed prize pot, defining a new era for showjumping. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260330990938/en/ Photography credits: Daniel Benson for The Premier Jumping League/ Wieden+Kennedy London Backed by McCourt Global and its Executive Chairman, Frank McCourt, the PJL is a groundbreaking global competition that e

Dompé Announces First Patient Enrolled in New Study of Intranasal NGF in Cerebral Palsy30.3.2026 11:00:00 CEST | Press release

Cerebral Palsy (CP) refers to a group of permanent disorders in the development of movement and posture, which causes activity limitations, and is attributed to non-progressive disturbances that occurred in the developing fetal or infant brain.1 Nerve growth factor (NGF) is a naturally-occurring protein that supports damaged nerve cells and improves nervous system signaling, Dompé is investigating whether intranasal NGF has the potential to improve movement and neurodevelopment and address underlying brain damage in people with CP. Dompé’s intranasal NGF platform builds on the Nobel Prize-winning discovery of neurobiologist Professor Rita Levi-Montalcini and biochemist Dr. Stanley Cohen. Dompé, a leading biopharmaceutical company with operations in Italy and in the U.S., announced that the first patient has been enrolled at the Agostino Gemelli IRCCS University Hospital in Rome, Italy, in a Phase 2 investigational study of an intranasal form of Nerve Growth Factor (NGF) (Cenegermin-bkb

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye